Skip to content
TrialScanner

NCT03573908

A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

Phase 3CompletedIRWDLeadABBVCollaborator

Registry record

Lead sponsor
Ironwood Pharmaceuticals, Inc.
Conditions
Irritable Bowel Syndrome Characterized by Constipation
Primary completion
Mar 13, 2019Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03573908 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03573908: A Trial of Linaclotide 290... | TrialScanner